FDA broadens access to GSK's respiratory syncytial virus shot for younger high-risk adults

On Friday, the U.S. Food and Drug Administration (FDA) expanded the approved age indication for GSK plc’s GSK respiratory ...
Clinical Advisor

RSV Vaccine Arexvy Approved for At-Risk Adults Aged 18 to 49 Years

Adults aged 18 to 49 years at increased risk for RSV-associated lower respiratory tract disease are now eligible for the ...

HMPV is circulating. What Kansans should know about respiratory virus

HMPV, a respiratory virus with no vaccine, is circulating. Learn its symptoms, how it spreads and who is at risk.
Science Daily

Antibiotics aren't effective for most lower tract respiratory infections

Use of antibiotics provided no measurable impact on the severity or duration of coughs even if a bacterial infection was present, finds a large, prospective study of people who sought treatment in U.S ...
Detroit Free Press

Rural Americans more likely to die early from preventable causes, CDC reports

The 46 million Americans who lived in rural parts of the country in 2022 were more likely to die before their 80th birthday from one of the top causes of death — heart disease, cancer, unintentional ...